InvestorsHub Logo
icon url

McMagyar

09/27/16 2:01 AM

#76261 RE: XenaLives #76254

Xena, this may be a good read. Giving BP A2-73 and A3-71 could be like Bayer giving up Aspirin.

Like the Cubs Trading Lou Brock!

Sometimes you just have to wait. We have plenty of BP exes working for Anavex..lots of connections to BP ..
The adaptive design article was great that was posted earlier. Investors will take chances with a visionary..

Some people were talking about milestones..for the Capital spent over the last two years..i could list 5 milesones right off the top of my weak mind..
Rett Syndrom, Infantile Spasms, Phase 2a Safety..Phase 2a MTD, Phase 2a Efficacy..
didn't mention A3-71..how soon will that be in Hu Trials to begin safety protocols.s.
And how about our rec3ent Milestone with Micharl J Fox Foundation?
The Public Crediblity factor is OFF THE CHARTS!

Yea..diss MJFF and see what happens to you Motley or Fuerstein or Cory or Wendy or Rosen or ...their game is over..
ACCUMULATE..